|
Consumers survey results of for 3 quarter of 2024 in category Gynecology, urology, nephrology / Medication for the treatment of climacteric disorders
 The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year. |
 |
I quarter (january—march) |
 |
II quarter (april—june) |
 |
III quarter (july—september) |
 |
IV quarter (october—december) |
|
| 1. |
Клімадинон (Bionorica)
|
50.00% |
5 |
|
|
| 1. |
Клімаксан (Materia Medica – Ukraine)
|
50.00% |
5 |
|
|
| 1. |
Клімакт-хеель (Heel) |
50.00% |
5 |
|
|
| 1. |
Клімакто-гран (Національна гомеопатична спілка)
|
50.00% |
5 |
|
|
| 1. |
Ременс (Perrigo)
|
50.00% |
5 |
|
|
| –. |
Естрожель (Besins Healthcare) |
0.00% |
0 |
 |
| –. |
Клімактоплан (DHU) |
0.00% |
0 |
|
|
| –. |
Клімапін (Red star)
|
0.00% |
0 |
|
|
| –. |
Клеверол (Jadran)
|
0.00% |
0 |
|
|
| –. |
Лайфемин (Pro-Pharma)
|
0.00% |
0 |
|
|
| –. |
Матрона (Талион-А) |
0.00% |
0 |
|
|
| –. |
Менопейс (Vitabiotics Ltd) |
0.00% |
0 |
|
|
| –. |
Мулімен (Heel)
|
0.00% |
0 |
|
|
| –. |
Онагрис (Сперко Україна)
|
0.00% |
0 |
|
|
| –. |
Трібестан (Sopharma) |
0.00% |
0 |
|
|
| –. |
Циміциплант (Schwabe) |
0.00% |
0 |
|
| |
The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.
